A Day Up For Checkpoint Therapeutics, Inc.
Fri 17 Jul 20 at 05:30 PM
Checkpoint Therapeutics, Inc. (CKPT:NASDAQ) rocketted at $2.24, a gain of 33.8%. The stock appeared on our News Catalysts scanner on Thu 16 Jul 20 at 04:41 PM in the 'MISCELLANEOUS' category. From Thu 02 Jul 20, the stock recorded 33.33% Up Days and 30.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Checkpoint Therapeutics, Inc. (CKPT:NASDAQ)
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company which focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers.
Top 10 Gainers:
- Verona Pharma plc (VRNA:NASDAQ), 111.62%
- Salem Media Group, Inc. (SALM:NASDAQ), 80.95%
- Cohen & Company Inc. (COHN:NYSEMKT), 54.14%
- AutoWeb, Inc. (AUTO:NASDAQ), 44.27%
- Ocwen Financial Corporation (OCN:NYSE), 42.1%
- Vaccinex, Inc. (VCNX:NASDAQ), 40.28%
- Allena Pharmaceuticals, Inc. (ALNA:NASDAQ), 38.46%
- Sunlands Technology Group (STG:NYSE), 34.23%
- Checkpoint Therapeutics, Inc. (CKPT:NASDAQ), 33.83%
- ClearPoint Neuro, Inc. (CLPT:NASDAQ), 33.15%